Clal Insurance Enterprises Holdings LTD Biomarin Pharmaceutical Inc Transaction History
Clal Insurance Enterprises Holdings LTD
- $9.68 Billion
- Q1 2025
A detailed history of Clal Insurance Enterprises Holdings LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Clal Insurance Enterprises Holdings LTD holds 72 shares of BMRN stock, worth $4,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72
Previous 16
350.0%
Holding current value
$4,296
Previous $1,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
666Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.36 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.13 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.06 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$892 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$644 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...